Commonwealth Equity Services’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Commonwealth Equity Services’s Portfolio MBVX Stock Details MBVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-27,865	Closed	-$24K	–	2906
2018 Q2	$24K	Buy	27,865 +15,662	+128%	+$19.8K	﹤0.01%	2714
2018 Q1	$18K	Buy	+12,203	New	+$26.4K	﹤0.01%	2667

Other funds holding MBVX

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Commonwealth Equity Services's MBVX Position: Q3 2018 in Review

Commonwealth Equity Services sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q3 2018, closing a stake of 27,865 shares — an estimated $24K sold.

Commonwealth Equity Services first reported a position in MBVX in Q1 2018 and held it in 2 quarters. The position peaked at $24K in Q2 2018. 2 funds tracked by Wall St. Rank hold MBVX as of Q3 2018.

Commonwealth Equity Services reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q3 2018 after selling out during the quarter.
Commonwealth Equity Services sold 27,865 MABVAX THERAPEUTICS HLDGS INC shares in Q3 2018, an estimated $24K.
Commonwealth Equity Services first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q1 2018 and held it in 2 quarters.
Commonwealth Equity Services's MABVAX THERAPEUTICS HLDGS INC position peaked at $24K in Q2 2018.
2 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q3 2018.

Based on Commonwealth Equity Services's 13F filing for Q3 2018, filed 6 Nov 2018.